Media: U.S. biotech Axcella seeks funds for long COVID drug shown to ease fatigue - Bloomberg News
14/04/2023 11:31
-- Source link: https://bloom.bg/3mupytA
-- Note: Reuters has not verified this story and does not
vouch for its accuracy
((Bengaluru newsroom, globalnewsmonitoring@thomsonreuters.com))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment